GO
Loading...

Teva Acquires Ratiopharm

Friday, 19 Mar 2010 | 9:06 AM ET

Teva announces it beat out Pfizer in a $5B deal for a privately held generic drug-maker in Germany, with William Marth, Teva Pharmaceutical North America CEO and CNBC's Mike Huckman.